159 related articles for article (PubMed ID: 8188295)
1. The DCC gene: structural analysis and mutations in colorectal carcinomas.
Cho KR; Oliner JD; Simons JW; Hedrick L; Fearon ER; Preisinger AC; Hedge P; Silverman GA; Vogelstein B
Genomics; 1994 Feb; 19(3):525-31. PubMed ID: 8188295
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
4. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
5. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
6. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
7. DCC expression is altered by multiple mechanisms in brain tumours.
Ekstrand BC; Mansfield TA; Bigner SH; Fearon ER
Oncogene; 1995 Dec; 11(11):2393-402. PubMed ID: 8570191
[TBL] [Abstract][Full Text] [Related]
8. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
9. [Structure and function of DCC (deleted in colorectal cancer) gene and its product].
Aoyama N; Minami R; Fujimori T; Maeda S
Nihon Rinsho; 1996 Apr; 54(4):972-80. PubMed ID: 8920659
[TBL] [Abstract][Full Text] [Related]
10. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
12. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.
Miyake S; Nagai K; Yoshino K; Oto M; Endo M; Yuasa Y
Cancer Res; 1994 Jun; 54(11):3007-10. PubMed ID: 8187090
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
Thiagalingam S; Lengauer C; Leach FS; Schutte M; Hahn SA; Overhauser J; Willson JK; Markowitz S; Hamilton SR; Kern SE; Kinzler KW; Vogelstein B
Nat Genet; 1996 Jul; 13(3):343-6. PubMed ID: 8673134
[TBL] [Abstract][Full Text] [Related]
15. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
16. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
[TBL] [Abstract][Full Text] [Related]
18. The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules.
Fearon ER; Pierceall WE
Cancer Surv; 1995; 24():3-17. PubMed ID: 7553661
[TBL] [Abstract][Full Text] [Related]
19. Identification of a chromosome 18q gene that is altered in colorectal cancers.
Fearon ER; Cho KR; Nigro JM; Kern SE; Simons JW; Ruppert JM; Hamilton SR; Preisinger AC; Thomas G; Kinzler KW
Science; 1990 Jan; 247(4938):49-56. PubMed ID: 2294591
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
